No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
From the perspective of treatable traits, it is necessary to evaluate the problems of individual asthma patients and proactively address treatable rhinosinusitis if available.
In Japan, a definitive diagnosis of eosinophilic sinusitis is made when the Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis Study (JESREC) score is 11 or higher, and the eosinophil count in nasal polyp tissue is 70 cells/400 times. Severity is stratified by the eosinophil percentage in peripheral blood, the location of sinus lesions, and comorbidities. While a definitive diagnosis of ECRS requires histological findings of nasal polyps, the use of systemic steroids and biological agents can make diagnosis difficult. Therefore, as an internist, it is desirable to prioritize diagnosis by an otolaryngologist before proceeding with these treatments whenever possible.
Dupilumab and mepolizumab are expected to be effective against both eosinophilic sinusitis and severe asthma. In the treatment of severe asthma patients, understanding “treatable treats” such as rhinosinusitis is important.
We examined patients with severe asthma and/ or eosinophilic sinusitis treated with biologic therapies at our hospital during the period between December 2025 and February 2026.
Between December 2025 and February 2026, 47 patients with asthma or eosinophilic sinusitis received antibody therapy at our hospital. Of these, 28 were receiving treatment for eosinophilic sinusitis, and 5 were diagnosed with eosinophilic sinusitis and treated after screening by internal medicine specialists. All of these patients suffered from severe asthma, and close collaboration between otolaryngologists and internists was essential in each case, including managing asthma treatment, coordinating treatment for diagnosis of eosinophilic sinusitis, and deciding on treatment after diagnosis.
Collaboration between otolaryngologists and internists is indispensable in the treatment of severe asthma.